Acadian Asset Management
MTCR

Acadian Asset Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Acadian Asset Management’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-84,442
Closed -$56K – 1873
2021
Q4 		$56K Buy
+84,442
New +$151K ﹤0.01% 1469

Other funds holding MTCR

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management's MTCR Position: Q1 2022 in Review

Acadian Asset Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2022, closing a stake of 84,442 shares — an estimated $56K sold.

Acadian Asset Management first reported a position in MTCR in Q4 2021 and held it in 1 quarter. The position peaked at $56K in Q4 2021. 31 funds tracked by Wall St. Rank hold MTCR as of Q1 2022.

  • Acadian Asset Management reported no remaining Metacrine, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Acadian Asset Management sold 84,442 Metacrine, Inc. Common Stock shares in Q1 2022, an estimated $56K.
  • Acadian Asset Management first reported a position in Metacrine, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Acadian Asset Management's Metacrine, Inc. Common Stock position peaked at $56K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2022.

Based on Acadian Asset Management's 13F filing for Q1 2022, filed 12 May 2022.